We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Acceptys and OncoMab Announce Integration of Human Antibody Drug Development Pipeline and Operations

News   Dec 26, 2005

 
Acceptys and OncoMab Announce Integration of Human Antibody Drug Development Pipeline and Operations
 
 
Advertisement
 

RELATED ARTICLES

SARS-CoV-2 Interactome Reveals Likely Molecular Mechanisms of Pathogenesis

News

University of Alabama at Birmingham researchers, led by Shahid Mukhtar, Ph.D., associate professor of biology in the UAB College of Arts and Sciences, have now built an interactome that includes the lung-epithelial cell host interactome integrated with a SARS-CoV-2 interactome.

READ MORE

182 Genes Identified That Regulate Interactions Between Cancer Cells and T Cells

News

Toronto scientists have mapped the genes allowing cancer cells to avoid getting killed by the immune system that paves the way for the development of immunotherapies that would be effective for larger patient populations and across different tumour types.

READ MORE

$111 Million NIH Grant Awarded To Combat HIV-Associated Cancers

News

For 25 years, the AIDS Malignancy Consortium (AMC) has led national and international efforts to prevent and treat of HIV-related cancers. Now, Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from the National Cancer Institute (NCI) to lead this research consortium.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE